Levonantradol
Structural formula | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
![]() |
||||||||||
General | ||||||||||
Surname | Levonantradol | |||||||||
other names |
(CP 50,556-1) |
|||||||||
Molecular formula | C 27 H 35 NO 4 | |||||||||
External identifiers / databases | ||||||||||
|
||||||||||
Drug information | ||||||||||
Drug class |
Antemetic, analgesic |
|||||||||
Mechanism of action |
Activation of the cannabinoid receptors CB1 and CB2 |
|||||||||
properties | ||||||||||
Molar mass | 437.57 g · mol -1 | |||||||||
safety instructions | ||||||||||
|
||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Levonantradol is a synthetic analogue of tetrahydrocannabinol and is therefore one of the cannabinoids .
Effects
Levonantradol activates the cannabinoid receptors CB 1 and CB 2 and thus mediates antiemetic and analgesic effects.
Levonantradol is currently meaningless as a medicinal substance and is used exclusively as a test substance in the search for active substances for cannabinoids.
Individual evidence
- ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
- ^ A b M. Ross Johnson, George M. Milne: Recent discoveries in the search for non-opiate analgetics. In: Journal of Heterocyclic Chemistry. 17, 1980, p. 1817, doi : 10.1002 / jhet.5570170841 .